$2.64
0.041.54%
Last update: 9:25 AM
15 minutes delayed
Comments
Loading...
Cardiff Oncology
CRDFNASDAQ
Cardiff Oncology (CRDF) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCardiff Oncology (NASDAQ:CRDF) Stock Quotes, Forecast and News Summary
Cardiff Oncology Stock (NASDAQ: CRDF) stock price, news, charts, stock research, profile.
| Open | $2.57 |
| Close | - |
| Volume / Avg. | 143.10K / 723.75K |
| Day Range | 2.49 - 2.62 |
| 52 Wk Range | 0.94 - 6.42 |
| Market Cap | $118.11M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 48 |
| Short Interest | 9.71% |
| Days to Cover | 3.52 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Cardiff Oncology Inc
Sector
Health Care
Industry
Biotechnology
Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-valid...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cardiff Oncology (CRDF) stock?
You can purchase shares of Cardiff Oncology (NASDAQ:CRDF) through any online brokerage.
Who are Cardiff Oncology (CRDF) competitors?
Other companies in Cardiff Oncology’s space includes: Anixa Biosciences (NASDAQ:ANIX), CytomX Therapeutics (NASDAQ:CTMX), Cellectar Biosciences (NASDAQ:CLRB), T2 Biosystems (NASDAQ:TTOO) and FibroGen (NASDAQ:FGEN).
What is the target price for Cardiff Oncology (CRDF) stock?
There is no analysis for Cardiff Oncology.
What is the forecast for Cardiff Oncology (CRDF) stock?
Cardiff Oncology has a consensus price target of $9.00.
Current stock price for Cardiff Oncology (CRDF)?
The stock price for Cardiff Oncology (NASDAQ: CRDF) is $2.64 last updated Today at July 17, 2024 at 9:25 AM EDT.
Does Cardiff Oncology (CRDF) pay a dividend?
There are no upcoming dividends for Cardiff Oncology.
When is Cardiff Oncology (NASDAQ:CRDF) reporting earnings?
Cardiff Oncology’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
Is Cardiff Oncology (CRDF) going to split?
There is no upcoming split for Cardiff Oncology.
What sector and industry does Cardiff Oncology (CRDF) operate in?
Cardiff Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.